AB-FUBICA
From Wikipedia, the free encyclopedia
 |
|
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
|
|
| CAS Number | 1801338-22-6  |
| ChemSpider | 57427397 |
| Chemical and physical data | |
| Formula | C21H22FN3O2 |
| Molar mass | 367.42 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
AB-FUBICA is a drug that acts as a potent agonist for the cannabinoid receptors, with EC50 values of 21 nM at CB1 and 15 nM at CB2.[1][2]
See also[edit]
References[edit]
- ^ Banister, Samuel D.; Moir, Michael; Stuart, Jordyn; Kevin, Richard C.; Wood, Katie E.; Longworth, Mitchell; Wilkinson, Shane M.; Beinat, Corinne; Buchanan, Alexandra S.; Glass, Michelle; Connor, Mark; McGregor, Iain S.; Kassiou, Michael (2015). "Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA". ACS Chemical Neuroscience. 6 (9): 1546. doi:10.1021/acschemneuro.5b00112. PMID 26134475.
- ^ Zhenhua Qian; Zhendong Hua; Cuimei Liu; Wei Jia (November 2015). "Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances". Forensic Toxicology. doi:10.1007/s11419-015-0297-2.
 |
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |
